Literature DB >> 12205684

Tau EGFP embryonic stem cells: an efficient tool for neuronal lineage selection and transplantation.

Marius Wernig1, Kerry Lee Tucker, Volker Gornik, Angelika Schneiders, Rachel Buschwald, Otmar D Wiestler, Yves-Alain Barde, Oliver Brüstle.   

Abstract

Pluripotency and the capacity for continuous self-renewal make embryonic stem (ES) cells an attractive donor source for cell-replacement strategies. A key prerequisite for a therapeutic application of ES cells is the generation of defined somatic cell populations. Here we demonstrate that a targeted insertion of the EGFP gene into the tau locus permits efficient fluorescence-activated cell sorting (FACS)-based lineage selection of ES cell-derived neurons. After in vitro differentiation of heterozygous tau EGFP ES cells into multipotent neural precursors, EGFP is selectively induced in postmitotic neurons of various neurotransmitter phenotypes. By using FACS, ES cell-derived neurons can be enriched to purities of more than 90%. Because neuron-specific EGFP fluorescence is also observed upon transplantation of ES cell-derived neural precursors, the tau EGFP mutant represents a useful tool for the in vivo analysis of grafted ES cell-derived neurons. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205684     DOI: 10.1002/jnr.10395

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

1.  Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells.

Authors:  Ernesto Lujan; Soham Chanda; Henrik Ahlenius; Thomas C Südhof; Marius Wernig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

3.  Direct conversion of human fibroblasts to dopaminergic neurons.

Authors:  Ulrich Pfisterer; Agnete Kirkeby; Olof Torper; James Wood; Jenny Nelander; Audrey Dufour; Anders Björklund; Olle Lindvall; Johan Jakobsson; Malin Parmar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

4.  Generation of induced pluripotent stem cells with high efficiency from human embryonic renal cortical cells.

Authors:  Ling Yao; Ruifang Chen; Pu Wang; Qi Zhang; Hailiang Tang; Huaping Sun
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 5.  Transdifferentiation of Fibroblasts by Defined Factors.

Authors:  Zhiliang Zhao; Mengyao Xu; Meng Wu; Xiaocheng Tian; Cuiping Zhang; Xiaobing Fu
Journal:  Cell Reprogram       Date:  2015-06       Impact factor: 1.987

6.  Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not.

Authors:  Vassiliki Nikoletopoulou; Heiko Lickert; José Maria Frade; Chantal Rencurel; Patrizia Giallonardo; Lixin Zhang; Miriam Bibel; Yves-Alain Barde
Journal:  Nature       Date:  2010-09-02       Impact factor: 49.962

7.  Direct lineage conversion of terminally differentiated hepatocytes to functional neurons.

Authors:  Samuele Marro; Zhiping P Pang; Nan Yang; Miao-Chih Tsai; Kun Qu; Howard Y Chang; Thomas C Südhof; Marius Wernig
Journal:  Cell Stem Cell       Date:  2011-09-29       Impact factor: 24.633

Review 8.  The role of single-cell analyses in understanding cell lineage commitment.

Authors:  Tyler M Gibson; Charles A Gersbach
Journal:  Biotechnol J       Date:  2013-03-21       Impact factor: 4.677

Review 9.  Stem cells for ischemic brain injury: a critical review.

Authors:  Terry C Burns; Catherine M Verfaillie; Walter C Low
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

10.  Direct conversion of fibroblasts to functional neurons by defined factors.

Authors:  Thomas Vierbuchen; Austin Ostermeier; Zhiping P Pang; Yuko Kokubu; Thomas C Südhof; Marius Wernig
Journal:  Nature       Date:  2010-01-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.